Study Evaluating Intravenous CMD-193 in Subjects With Advanced Malignant Solid Tumors

NCT00257881 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer